Review





Similar Products

rabbit anti pp2ac antibody  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc rabbit anti pp2ac antibody
Rabbit Anti Pp2ac Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti pp2ac antibody/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
rabbit anti pp2ac antibody - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
pp2ac  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc pp2ac
IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
Pp2ac, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pp2ac/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
pp2ac - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
rabbit anti pp2a  (Bethyl)
93
Bethyl rabbit anti pp2a
IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
Rabbit Anti Pp2a, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti pp2a/product/Bethyl
Average 93 stars, based on 1 article reviews
rabbit anti pp2a - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
rabbit anti pp2a catalytic subunit  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc rabbit anti pp2a catalytic subunit
IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
Rabbit Anti Pp2a Catalytic Subunit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti pp2a catalytic subunit/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
rabbit anti pp2a catalytic subunit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
rabbit monoclonal anti pp2ac  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc rabbit monoclonal anti pp2ac
IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
Rabbit Monoclonal Anti Pp2ac, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal anti pp2ac/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
rabbit monoclonal anti pp2ac - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
anti pp2a c subunit antibody  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc anti pp2a c subunit antibody
IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
Anti Pp2a C Subunit Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pp2a c subunit antibody/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
anti pp2a c subunit antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
rabbit polyclonal anti pp2a c subunit  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc rabbit polyclonal anti pp2a c subunit
IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
Rabbit Polyclonal Anti Pp2a C Subunit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti pp2a c subunit/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
rabbit polyclonal anti pp2a c subunit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
rabbit anti ppp2r1a  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc rabbit anti ppp2r1a
IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for <t>PP2Ac,</t> pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.
Rabbit Anti Ppp2r1a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti ppp2r1a/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
rabbit anti ppp2r1a - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for PP2Ac, pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.

Journal: International Journal of Molecular Sciences

Article Title: Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk

doi: 10.3390/ijms27041841

Figure Lengend Snippet: IL-17A induces p53, PAI-1, Cav1 and apoptosis, and CSP or CSP7 inhibits IL-17A-induced apoptosis in AECs. ( A ) AECs isolated from uninjured WT and p53 −/− mice were treated with IL-17A (0–100 ng/mL) for 24 h, and the lysates were immunoblotted for p53, PAI-1, Cl./Cas-3 and β-actin. ( B ) WT mice received saline or IL-17A intranasally (0–3 μg in 50 μL saline), as previously described . AECs were isolated 24 h later, and lysates were immunoblotted for p53 and Cl./Cas-3 and β-actin. ( C ) WT mice were exposed to saline or IL-17A (1 μg), as described in ( B ). Lysates of AECs isolated 24 h after treatment with IL-17A were immunoblotted for ACp53, p53, Sirt1, Cav1 and apoptosis. ( D ) AECs isolated from WT mice were treated with PBS or IL-17A (100 ng/mL). Two hours later, IL-17A-stimulated cells were treated with or without CSP or CP (10 µM) and analyzed for p53, PAI-1 and apoptosis by Western blotting (WB). ( E ) AECs isolated from WT mice exposed to IL-17A (100 ng/mL) were treated with CSP, its overlapping deletion fragments, or control peptide (CP) for 24 h in vitro. The lysates were analyzed for ACp53, p53, PAI-1, Sirt1 and Cl. Cas-3 by WB. ( F ) miR-34a fl/fl mice and miR-34acKO mice lacking miR-34a in AECs were exposed to IL-17A (1 μg) with or without CSP7 or CP. Control mice were exposed to saline. Lysates from AECs extracted from these mice were analyzed for p53, PAI-1, Sirt1, Cav1 and apoptosis by WB. ( G ) Lung homogenates or lysates of AECs extracted from WT mice exposed to IL-17A with or without CSP7 or CP were subjected to WB for PP2Ac, pATM and ATM kinase. ( H ) Lung homogenates of IL-17A-exposed mice treated with or without CSP7 or CP were immunoprecipitated (IP) using anti-Cav1 antibody and immunoblotted for p53, mdm2, and PP2Ac. ( I ) Lung homogenates of WT mice exposed to saline or IL-17A with or without CSP7 were analyzed for MPO activity.

Article Snippet: 17 , PP2Ac , CST , 2259S , 1:1000 , .

Techniques: Isolation, Saline, Western Blot, Control, In Vitro, Immunoprecipitation, Activity Assay